主页文献库搜索
Identification of E545k mutation in plasma from a PIK3CA wild-type metastatic...

Romero(Atocha),Acosta-Eyzaguirre(Daniel),S... Transl Res 2016-03-21

...PIK3CA wild-type primary tumor in which the PIK3CA E545K mutation was identified in both the circulating-free DNA obtain...

Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal...

Bonelli(Mara A),Cavazzoni(Andrea),Saccani(... Mol Cancer Ther 2016-05-05

...PIK3CA-mutated SQCLC cells and in newly generated clones carrying PIK3CA alterations, as well as in a xenograft model. P...

Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Geno...

Meric-Bernstam(Funda),Brusco(Lauren),Shaw(... J Clin Oncol 2016-04-29

...PIK3CA/AKT1/PTEN/BRAF mutations that returned for therapy, 116 (50%) received a genotype-matched drug. Forty patients (1...

[Molecular analysis of sporadic colon cancer].

Hurtado(Claudia),Wielandt(Ana María),Zárat... Rev Med Chil 2016-04-21

...PIK3CA (E542K, E545D, E545K, Q546E, H1047R). BRAF mutations alone or in combination with PIK3CA mutations were observed ...

PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Ra...

Phipps(Amanda I),Ahnen(Dennis J),Cheng(Ion... Cancer Epidemiol Biomarkers... 2016-03-31

...PIK3CA). We evaluated the relationship of PIK3CA mutation status in colorectal cancer with race/ethnicity, colorectal ca...

Epidermal growth factor receptor pathway mutation and expression profiles in ...

Bumrungthai(Sureewan),Munjal(Kavita),Nande... J Transl Med 2016-03-17

...PIK3CA mutations by PNA-clamp real-time PCR. Immunohistochemistry (IHC) was performed for EGFR, PIK3CA, PTEN, phospho-AK...

A combination of molecular markers and clinical features improve the classifi...

Springer(Simeon),Wang(Yuxuan),Dal Molin(Ma... Gastroenterology 2016-04-07

...PIK3CA, RNF43, SMAD4, TP53, and VHL); to identify loss of heterozygozity at CDKN2A, RNF43, SMAD4, TP53, and VHL tumor su...

De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast ...

Madrid-Paredes(Adela),Cañadas-Garre(Marisa... Pharmacogenomics 2016-06-16

...PIK3CA or AKT1, cannot be fully established yet.

Tumour pharmacodynamics and circulating cell free DNA in patients with refrac...

Wong(Andrea Li Ann),Lim(Joline Si Jing),Si... J Transl Med 2016-01-13

...PIK3CA and BRAF were detected in plasma circulating cell free DNA in 14 patients; some mutations were not found in archi...

Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastat...

Janjigian(Yelena Y),Vakiani(Efsevia),Ku(Ge... PLoS One 2016-05-16

...PIK3CA, and TP53, and focal amplifications of HMGA2 and MET.,Sorafenib therapy results in disease stabilization and enco...

上一页 112 113 114 115 116 117 118 119 120 下一页 116 / 共 353

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com